期刊文献+

脱氧皮质酮诱导大鼠心肌纤维化及阿利吉仑干预的影响 被引量:2

Effect of aliskiren on myocardial fibrosis induced by desoxycorticosterone acetate-salt
暂未订购
导出
摘要 目的探讨阿利吉仑对脱氧皮质酮诱导的大鼠心肌纤维化的影响及其相关机制。方法将45只SD大鼠行右肾切除,术后予1%氯化钠饮水4周并随机分为3组:对照(A)组、脱氧皮质酮(B)组、脱氧皮质酮+阿利吉仑(C)组。颈动脉插管测大鼠平均动脉血压(MABP),大鼠心脏组织经天狼猩红染色测定心肌间质胶原容积分数(CVF)和心肌血管周围胶原面积比(PVCA)的表达,Western blot法测定细胞外信号调节激酶1/2(ERK1/2)、磷酸化细胞外信号调节激酶(pERK1/2)和基质金属蛋白酶9(MMP9)的含量,免疫放射检测血浆及心肌组织的肾素活性(RA)及血管紧张素Ⅱ(AngⅡ)的含量。结果与A、C组比较,B组的MABP水平和CVF、PVCA的表达以及心肌组织中ERK1/2、pERK1/2、MMP9的含量显著升高(P<0.05);与A组比较,B组及C组血浆及心肌组织中的RA、AngⅡ的含量显著减低(P<0.05);与B比较,C组心肌纤维化程度和心肌组织中的ERK1/2、pERK1/2、MMP9、RA、AngⅡ的含量明显减少(P<0.05),而血浆中的RA、AngⅡ的含量和MABP水平减少不明显。结论阿利吉仑能改善脱氧皮质酮诱导的心肌纤维化,其机制可能与抑制心肌局部肾素-血管紧张素-醛固酮系统、减少AngⅡ生成及ERK1/2途径的传导和MMP9的表达有关。 Objective To investigate the effects and mechanisms of aliskiren on myocardial fibrosis induced by desoxycorticosterone acetate-salt in rats.Methods Forty-five SD rats which were uninephrectomized were limited to drink 1% NaCl water for 4 weeks and assigned to the follow groups:vehicle control rats(A group),desoxycorti-costerone acetate-salt treated rats(B group),aliskiren+desoxycorticosterone acetate treated rats(C group).Blood pressure were measured with catheterization.Collagen volume fraction(CVF)and perivascular collagen area(PVCA)were analyed by Sirius red staining.MMP9,ERK1/2,pERK1/2 were detected by Western blot.RA and AngⅡ were detected by radiommoassay(RIA).Results Compared with B group,MABP of C group and A group were elevated,and significant difference was observed(P〈0.05),but mean arterial blood pressure of C group was not decreased significantly.Myocardial fibrosis was observed in B group.Compared with the other two groups,the index of CVF and PVCA were increased significantly(P〈0.05).Compared with C group,the levels of MMP9,ERK1/2,pERK1/2,local tissue RA and Ang Ⅱ were significantly increased in B group(P〈0.05),but RA and Ang Ⅱ in plasma were no significantly decreased.Conclusion Aliskiren may attenuate myocardial fibrosis induced by desoxycorticosterone acetate-salt independent of blood.Local tissue generation of Ang Ⅱ may be responsible for the results.
出处 《安徽医科大学学报》 CAS 北大核心 2011年第5期427-430,共4页 Acta Universitatis Medicinalis Anhui
关键词 肾素/拮抗剂和抑制剂 脱氧皮质酮 renin/antagonists & inhibitors desoxycorticosterone
  • 相关文献

参考文献11

  • 1Singh V P,Le B, Khode R, et al. Intracellular angiotensin II pro- duction in diabetic: rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis [ J ]. Diabetes, 2008,57 ( 12, ) : 3297 - 306.
  • 2Westemmnn D, Riad A, Lettau O, et al. Renin inhibition improves cardiac function and remodeling after myocardial infarction inde- pendent of blood pressure [ J ]. Hypertension,2008,52 (6) : 1068 - 75.
  • 3Xu J, Carretero O A, Liao T D, et al. Local angiotensin II aggra- vates cardiac remodeling in hypertension [ J ]. Am J Physiol Heart Circ Physio1,2010 ,299 (5) :H1328 - 38.
  • 4Zhong J C, Basu R,Guo D,et al. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardi- ac dysfunction [ J ]. Circulation,2010,122 ( 7 ) : 117 - 28.
  • 5Johar S, Cave A C, Narayanapanicker A, et al. Aldosterone medi- ates angintensin H -induced interstitial cardiac fibrosis via a Nox2- containing NADPH oxidase [ J]. FASEB J,2006,20 (9) :1546 -8.
  • 6Nussberger J,Wuerzner G,Jensen C,et al. Angiotensin II suppres-sion in humans by the orally active renin inhibitor aliskiren ( SPP100 ) : comparison with enalapril [ J ]. Hypertension, 2002,39 (1) :E1 -8.
  • 7De Mello W C. On the pathophysiological implications of an intra- cellular renin receptor[J]. Circ Res,2006,99(12) :1285 -6.
  • 8赵胜,刘伏元,崇爱国,孟培娜,严激.巨噬细胞和组织血管紧张素Ⅱ在动脉粥样硬化兔腹主动脉狭窄前后血管内膜的变化[J].安徽医科大学学报,2008,43(6):646-650. 被引量:3
  • 9Susic D,Varagic J , Frohlich E D. Cardiovascular effects of inhibi- tion of renin-angiotensin-ahtosterone system components in hyper- tensive rats given salt excess[ J]. Am J Physiol Heart Cire Physiol, 2010,298(4) : H1177 -81.
  • 10Frohlieh E D. The salt conundrum : a hypothesis [ J ]. Hypertension 2007,50(1) :161 -6.

二级参考文献15

  • 1周希,李法琦,余江恒,苟晓燕,史若飞.替米沙坦对高血压大鼠纤溶功能的作用机制[J].中华高血压杂志,2006,14(8):651-655. 被引量:13
  • 2何学令,尹海林.动脉粥样硬化动物模型研究的现状及存在的问题[J].实验动物科学与管理,2006,23(4):41-44. 被引量:11
  • 3Nobuhiko A, Suganuma E, Babaev V R, et al. Angiotensin Ⅱ Amplifies Macrophage-Driven Atherosclerosis [ J ]. Arterioscler Thromb Vasc Biol, 2004, 24 ( 11 ) :2143 - 8.
  • 4Johnson J L, Baker A H, Oka K, et al. Suppression of atherosclerotic plaque progression and instability by tissue inhibitor of metalloproteinase-2 : involvement of macrophage migration and apoptosis [J]. Circulation,2006,113(20):2435 -44.
  • 5Jacoby D S, Rader D J. Renin-angiotensin system and atherthrombotic disease [ J ]. Arch Intern Med, 2003, 163 (22) : 1155 - 64.
  • 6Re R N. Tissue renin angiotensin systems [ J]. Med Clin North Am, 2004 ,88(1) :19 -38.
  • 7Campbell D J. Circulation and tissue angiotensin system [ J ]. Clinical Investigation, 1987, 79 ( 1 ) : 1 - 6.
  • 8Rosendorff C. The renin angiotensin system and vascular hypertrophy[J]. J Am Coil Cardiol, 1996, 28(4):803 -12.
  • 9Miyazaki M, Takai S. Tissue angiotensin Ⅱ generating system by angiotensin-converting enzyme and chymase [ J ]. J Pharmacol Sci, 2006, 100(5) :391 -7.
  • 10Dahlof B, Sever P S, Poulter N R,et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial- Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial[ J]. Lancet, 2005, 366(9489) :895 - 906.

共引文献2

同被引文献36

  • 1Sun Y. Intracardiac renin-angiotensin system and myocardial repair/remodeling following infarction [ J ]. J Mol Cell Cardi- ol,2010,48 (3) :483-489.
  • 2Mehta PK, Griendling KK. Angiotensin Ⅱ cell signaling:physi- ological and pathological effects in the cardiovascular system [ J]. Am J Physiol Cell Physiol,2007,292 ( 1 ) :C82-C97.
  • 3Susic D, Varagic J, Frohlich ED. Cardiovascular effects of inhi- bition of ren in-ang iotens in-aldosteron e system components in hypertensive rats given salt excess [ J ]. Am J Physiol Heart Circ Physio1,2010,298 (4) : 1177-1181.
  • 4Higashikuni Y, Takaoka M, Iwata H, et al. Aliskiren in combi- nation with valsartan exerts synergistic protective effects a- gainst ventricular remodeling after myocardial infarctio-n in mice[J]. Hypertension Research ,2012,35 ( 1 ) :62-69.
  • 5Yamamoto E, Kataoka K, Dong YF, et al. Aliskiren enhances the protective effects of valsartan against cardiovascular and renal Injury in endothelial nitric oxide synth-ase in deficient mice [ J ]. Hypertension,2009,54 ( 3 ) :633 -638.
  • 6Wang T, Wu DQ, Jiang XZ, et al. Novel thermosensitive hy- droGel injection inhibits post-infarct ventricle remodelling [J]. Eur J Heart Fail,2009,11 (1) :14-19.
  • 7Mahon NG, O'rorke C, Codd MB, et al. Hospitial mortality of acute myocardial infarction in the thrombolytic era[J]. Heart, 1999,81 (5) :478-482.
  • 8Hunt SA, Abraham WT, Chin MH, et al. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Di- agnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: devel- oped in collaboration with the International Society for Heart and Lung Transplantation [ J ]. Circulation, 2009,119 : e391- e479.
  • 9Bujak M,Frangogiannis NG. The role of TGF-I3 signaling in myocardial infarction and cardiac remodeling [ J ]. Cardiovasc Res,2007,74(2) :184-195.
  • 10Jessup M, Abraham WT, Casey DE, et al. 2009 focused up- date :ACCF/AHA Guidelines for the Diagnosis and Manage- ment of Heart Failure in Adults : a report of the American Col- lege of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines:developed in collaboration with the International Society for Heart and Lung Transplanta- tion [ J ]. Circulation 2009,119 ( 14 ) : 1977-2016.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部